Cannabis Report
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: Ubertino
Search This Board: 
Last Post: 9/18/2018 9:59:22 AM - Followers: 403 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

Cannabis Report
INO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Dan (Retired) 08/02/13 01:15:33 PM
#14279   Inovio Pharmaceuticals (NASDAQ:INO) was given a new $13.00 radly 09/18/18 09:59:21 AM
#14278   Hate so see it with not good news. radly 09/17/18 11:36:01 AM
#14277   Why 5% drop on good news? It’s not? . sage4 09/17/18 11:23:02 AM
#14276   Well there, looky looky, sub 5's again for radly 09/17/18 10:14:14 AM
#14275   Inovio Pharmaceuticals Inc (NASDAQ:INO) CEO Jong Joseph Kim radly 09/14/18 09:40:28 PM
#14274   Monthly chart looking good. 3-month chart looking good too! 7Bullet7 09/10/18 02:23:48 PM
#14273   No but I bet we can get back radly 09/06/18 05:55:22 PM
#14272   And..... here's the fall...... GolfFishSurf 09/06/18 12:29:27 PM
#14271   Nice steady climb. Can we get back into GolfFishSurf 09/05/18 05:39:37 PM
#14270   Hep. C - is that connected to vit. C? Ubertino 09/04/18 01:51:29 PM
#14269   News out. Going up. 7Bullet7 09/04/18 10:03:36 AM
#14268   If the past is any indication this will radly 08/31/18 07:16:20 PM
#14267   Close strong today, or will it pull back GolfFishSurf 08/31/18 12:44:29 PM
#14266   Not gonna happen. 7Bullet7 08/24/18 08:03:00 PM
#14265   Must be time for another Kim dilution. kpisme 08/24/18 12:15:42 PM
#14264   Looks like Ino is back on track. $5 ATVrider 08/23/18 06:49:23 PM
#14263   A little climb back up here.... is anyone GolfFishSurf 08/22/18 06:36:03 PM
#14262   * * $INO Video Chart 08-08-18 * * ClayTrader 08/08/18 05:13:40 PM
#14261   I'm no analyst!! Ubertino 08/08/18 10:23:20 AM
#14260   Inovio Pharmaceuticals (NASDAQ:INO) was given a new $13.00 radly 08/07/18 08:15:08 PM
#14259   Plymouth Meeting-based Inovio teams up with AIDS Malignancy Ubertino 08/06/18 01:22:17 PM
#14255   RAH RAH RAH radly 07/16/18 12:04:54 PM
#14254   https://www.nytimes.com/2018/07/11/health/gene-editing-cancer.html?smid=fb-nytim BossBZ 07/12/18 12:24:16 AM
#14253   Wonderful, more insider selling. radly 07/11/18 07:41:47 PM
#14252   Time to buy...just about as good as NNVC. Ubertino 06/30/18 09:20:24 AM
#14251   Time to triple down on ino! Patience, $$$ harry crumb 06/29/18 10:42:21 PM
#14250   MG - thanks for the 8¢ spike this AM. Ubertino 06/29/18 09:51:46 AM
#14248   INO I continue to vociferously denounce INO as MiamiGent 06/28/18 09:04:09 PM
#14247   Makes my purchases at $1 and 10¢ look stupid! Ubertino 06/28/18 12:39:40 PM
#14246   INO just hit NEW ALL TIME LOW? arvitar 06/28/18 10:41:39 AM
#14245   Dr. J. Joseph Kim, Inovio President and CEO, Ubertino 06/28/18 09:54:46 AM
#14244   Could tou explain why INO is seeking a CEO? Ubertino 06/28/18 08:42:01 AM
#14243   SP = $3.89 = Pathetic POS radly 06/27/18 05:38:00 PM
#14242   investorshub.advfn.com/uimage/uploads/2018/6/27/lkfdyx.png arvitar 06/27/18 04:22:36 PM
#14241   INO has a CEO! Ubertino 06/22/18 05:59:48 PM
#14240   SP = $4.19 = Pathetic radly 06/21/18 07:18:49 PM
#14239  Restored Any potential CEO would jump at the arvitar 06/21/18 02:55:22 PM
#14236   It's Green It's Green It's a miracle, It's radly 06/20/18 05:50:39 PM
#14234   Go INO!!!! Its_lose_not_loose 06/20/18 02:54:50 PM
#14233   Get in early, never get out. And avoid Ubertino 06/20/18 01:36:19 PM
#14232   investorshub.advfn.com/uimage/uploads/2018/6/20/iiiupx.png arvitar 06/20/18 12:17:47 PM
#14231   Get in early: Ubertino 06/15/18 06:19:05 PM
#14230   Look at that 2 year chart. How pathetic. radly 06/15/18 06:06:47 PM
#14229   I love shorts - wear them till they Ubertino 05/30/18 01:12:41 PM
#14228   Rogue Gambler 05/30/18 10:57:25 AM
#14227   Looks like you're shorting the stock. Smarten up ! 7Bullet7 05/30/18 10:15:13 AM
#14226   Bankruptcy? arvitar 05/29/18 08:57:46 PM
#14225   PPS after-hours Plane Crash due to PURE DILUTION OMG! kpisme 05/25/18 04:59:35 PM
#14224   Yes sir, look at this pps take off radly 05/21/18 01:49:05 PM
#14223   What's next is lower PPS radly 05/21/18 10:42:06 AM
PostSubject